Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R JESSUP

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
British Journal of Pharmacology|April 1, 1993
Redirection of arachidonic acid metabolism by ICI D1542: effects on thrombus formation in the coronary artery of the anaesthetized dogS J McAuliffe, J A Moors, H M Snow, et al.
Prostaglandins|August 1, 1988
The synthesis of a novel thromboxane receptor antagonist 4(Z)-6-(2-o-chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl) hexenoic acid ICI 192605A G Brewster, G R Brown, A J Foubister, et al.
The Journal of Organic Chemistry|September 22, 1972
11,15-Epiprostaglandin E 2 and its enantiomer. Biological activity and synthesisE J Corey, S Terashima, P W Ramwell, et al.
British Journal of Pharmacology|December 1, 1993
ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitroR P Brownlie, N J Brownrigg, H M Butcher, et al.
The Journal of Pharmacy and Pharmacology|February 1, 1997
ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dogR P Brownlie, N J Brownrigg, H M Butcher, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 31, 2025
Experience With Pediatric Extracorporeal Membrane Oxygenation (ECMO) Standby at Two High-Volume CentersChristopher Nemeh, Goeto Dantes, Caitlin Cain-Trivette, et al.
JACC. Heart Failure|June 17, 2026
Rebuilding U.S. Heart Failure Site-Based Research: A National Expert Authority Blueprint From the Heart Failure CollaboratoryMelvin R Echols, Mona Fiuzat, Douglas M Brinkley, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Pharmacology|April 1, 1993
Redirection of arachidonic acid metabolism by ICI D1542: effects on thrombus formation in the coronary artery of the anaesthetized dogS J McAuliffe, J A Moors, H M Snow, et al.
Prostaglandins|August 1, 1988
The synthesis of a novel thromboxane receptor antagonist 4(Z)-6-(2-o-chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl) hexenoic acid ICI 192605A G Brewster, G R Brown, A J Foubister, et al.
The Journal of Organic Chemistry|September 22, 1972
11,15-Epiprostaglandin E 2 and its enantiomer. Biological activity and synthesisE J Corey, S Terashima, P W Ramwell, et al.
British Journal of Pharmacology|December 1, 1993
ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitroR P Brownlie, N J Brownrigg, H M Butcher, et al.
The Journal of Pharmacy and Pharmacology|February 1, 1997
ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dogR P Brownlie, N J Brownrigg, H M Butcher, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 31, 2025
Experience With Pediatric Extracorporeal Membrane Oxygenation (ECMO) Standby at Two High-Volume CentersChristopher Nemeh, Goeto Dantes, Caitlin Cain-Trivette, et al.
JACC. Heart Failure|June 17, 2026
Rebuilding U.S. Heart Failure Site-Based Research: A National Expert Authority Blueprint From the Heart Failure CollaboratoryMelvin R Echols, Mona Fiuzat, Douglas M Brinkley, et al.
Pageof 2